Patrick Donnelly
Stock Analyst at Citigroup
(3.65)
# 16
Out of 4,918 analysts
333
Total ratings
51.4%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Buy | $34 | $28.04 | +21.26% | 1 | Jul 14, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $166.91 | +19.83% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $67.16 | +19.12% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $94.66 | -15.49% | 17 | Jul 9, 2025 | |
| BRKR Bruker | Downgrades: Neutral | $50 → $40 | $37.99 | +5.29% | 16 | May 22, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $284.60 | +22.98% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $290.05 | +20.67% | 15 | May 2, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $166.44 | +29.18% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,197.23 | +16.94% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $13.08 | +14.68% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.36 | +58.45% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $54.89 | +27.53% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $182.45 | +15.10% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $463.04 | +23.10% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $170.85 | +8.28% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $197.09 | +34.46% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $5.46 | +321.25% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $22.81 | +119.20% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $11.15 | +79.37% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $47.76 | +57.04% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $113.50 | +45.37% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $41.42 | +8.64% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $25.12 | +11.46% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $88.23 | +64.34% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $49.94 | +23.75% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $290.31 | +3.34% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.01 | +199.00% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.73 | +0.92% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $261.50 | -0.57% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $5.39 | +11.32% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $3.91 | +719.46% | 2 | Nov 30, 2018 |
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $34
Current: $28.04
Upside: +21.26%
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $166.91
Upside: +19.83%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $67.16
Upside: +19.12%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $94.66
Upside: -15.49%
Bruker
May 22, 2025
Downgrades: Neutral
Price Target: $50 → $40
Current: $37.99
Upside: +5.29%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $284.60
Upside: +22.98%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $290.05
Upside: +20.67%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $166.44
Upside: +29.18%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,197.23
Upside: +16.94%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $13.08
Upside: +14.68%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.36
Upside: +58.45%
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $54.89
Upside: +27.53%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $182.45
Upside: +15.10%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $463.04
Upside: +23.10%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $170.85
Upside: +8.28%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $197.09
Upside: +34.46%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $5.46
Upside: +321.25%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $22.81
Upside: +119.20%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $11.15
Upside: +79.37%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $47.76
Upside: +57.04%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $113.50
Upside: +45.37%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $41.42
Upside: +8.64%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $25.12
Upside: +11.46%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $88.23
Upside: +64.34%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $49.94
Upside: +23.75%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $290.31
Upside: +3.34%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.01
Upside: +199.00%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.73
Upside: +0.92%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $261.50
Upside: -0.57%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $5.39
Upside: +11.32%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $3.91
Upside: +719.46%